Get the latest tech news

FDA approves breakthrough drug daraxonrasib to treat pancreatic cancer

Experts have hailed the drug, daraxonrasib, as a game changer for one of the world's deadliest cancers.

None

Related news:

A Game-Changing Drug for Pancreatic Cancer Just Got FDA Approval

FDA approves first in class targeted therapy for metastatic pancreatic cancer

FDA approves world’s first dual-sensor CGM in diabetes 'breakthrough' — new Libre Duo sensor tracks ketones and blood sugar in real-time